PROFOUND MEDICAL CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$6.57
+12.12%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+12.3%
3 months
-20.3%
6 months
-4.2%
1 year
+7.3%
Year to date
-16.5%
52-week range
$5.06 – $8.65
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$240M
P/E
-10.3
P/B
6.8
P/S
17.6
Revenue
$19.09M
Net income
-$32.75M
Diluted EPS
-0.98
Gross margin
71.80%
Net margin
-171.60%
Return on equity
-63.00%
Total debt
$7.38M
Cash
$38.27M
Free cash flow
-$36.1M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $2.48M | -$9.54M | 78.40% | -384.20% | -$11.34M |
| Mar 31, 2026 | $5.34M | -$7.05M | 71.80% | -132.20% | -$8.58M |
| Dec 31, 2025 | $5.98M | -$8.18M | 66.80% | -136.80% | -$6.57M |
| Sep 30, 2025 | $5.29M | -$7.98M | 74.30% | -150.80% | -$9.61M |
| Jun 30, 2025 | $2.21M | -$15.7M | 73.20% | -709.90% | -$13.74M |
| Mar 31, 2025 | $2.62M | -$10.72M | 70.70% | -409.20% | -$8.28M |
| Dec 31, 2024 | $3.71M | -$9.69M | 68.10% | -261.60% | -$5.64M |
| Sep 30, 2024 | $2.83M | -$12.28M | 63.80% | -433.70% | -$6.36M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PROF news
All market newsNo ticker-linked stories are in the current archive.